07:30 AM EDT, 08/13/2026 (MT Newswires) -- Zenas BioPharma ( ZBIO ) reported a Q2 net loss Thursday of $1.77 per diluted share, widening from a loss of $1.25 per share a year earlier.

Analysts polled by FactSet expected a loss of $1.12 per share.

Revenue for the quarter ended June 30 was $1 million. No revenue was reported a year earlier.

Analysts expected $15 million.

The company said Chief Financial Officer Jennifer Fox will transition to the role of strategic advisor to the board chairman, effective Sept. 30. Zenas President and Chief Operating Officer Joe Farmer will serve as principal financial and accounting officer until a new CFO is appointed, the company added.